Download presentation
Presentation is loading. Please wait.
Published byJocelyn Chase Modified over 9 years ago
1
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital AHA Evidence Based Guidelines How to proceed with scant evidence
2
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Levels of Evidence 1
3
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Levels of Recommendation
4
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital AHA Guidelines Cocaine-Induced Ventricular Dysrhythmias l Recommended Therapies, Ordered By Preference: –Sodium Bicarbonate (IIB), Lidocaine (IIB), Alpha Adrenergic Blockers (IIB) l Inappropriate Therapies: –Non-Selective Beta Blockers, Epinephrine (Both III) Cocaine-Induced Acute Coronary Syndrome (ACS) l Recommended Therapies, Ordered by Preference: –Benzodiazepines (IIB), Nitrates (IIB), Alpha- Adrenergic Antagonists (IIB) l Inappropriate Therapies: –Non-Selective Beta-Blockers (III)
5
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital AHA Guidelines Calcium Channel Blocker Poisoning or Overdose l Recommended Therapies, Ordered By Preference: –Pacemaker, Vasopressors, High-Dose If Necessary(IIB), Calcium (IIB) Beta-Blocker Poisoning or Overdose l Recommended Therapies, Ordered By Preference: –Pacemaker, Vasopressors, High-Dose If Necessary (IIB), Glucagon (IIB)
6
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital AHA Guidelines Tricyclic Antidepressant Poisonings l Recommended Therapies, Ordered By Preference: –Sodium Bicarbonate (IIB), Lidocaine l Inappropriate Therapies: –Procainamide (III) Refractory Drug-Induced Shock l High-Dose Vasopressors (IIB), Circulatory Assist Devices (IIB), Vasopressin (Indeterminate)
7
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Opiate Poisoning: Ventilation before Naloxone? Dr Andrew Dawson Director Hunter Area Toxicology Service Newcastle, Australia
8
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Opiate Poisoning: Ventilation before Naloxone? “Evidence supports the correction of respiratory failure with bag valve mask techniques followed by administration of naloxone in any patient suspected of opioid induced respiratory failure.”
9
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Are all clinical situations the same? 24 year male recreational heroin OD 75 year male IHD post operative narcosis 24 year old post heroin OD respiratory arrest being ventilated
10
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Naloxone & Ventilation Grid
11
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Naloxone: Efficacy Animal –Good controlled studies Clinical data –Anaesthetic l Good controlled studies –Clinical Toxicology l Case series –indirectly address the issues
12
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Naloxone: Risk Incidence of possible ADR <1% Seizure & cardiac arrest –Extremely rare –Probably catecholamine mediated ? Pulmonary Oedema Behavioural 7%
13
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Naloxone & Catecholamines Increases catecholamine release –especially in the presence of hypercapnoea –The correction of of hypercapnoea reduces haemodynamic effects. l Mills CA (1988) There is no clinical evidence to support hypercapnoea correction prior to administration of naloxone.
14
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Mills et al
15
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Mills et al
16
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Naloxone Dose 0.12 mg endpoint ETCO 2 < 6.5% Tigerstedt Out of Hospital: Protocol Driven
17
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Respiratory Arrest/Depression Detectable pulse & BP >90% response to naloxone IV=IM –Sporer et al IV=SC –Wanger et al
18
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Opioids: Asystolic arrest Prehospital physician & paramedic medical team survival (4/7) –all IV naloxone l Bertini G et al 1992. Prehospital paramedic (0/16) –50% received naloxone IV l Sporer KA et al 1996
19
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Is Naloxone Neurotoxic? Glutamate mediated neuroexcito-toxicity Modulating effect of endorphines & morphine Direct effects of Naloxone
20
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Excitatory amino acids, glutamate Increased intracellular calcium and sodium Protein kinases C, II Proteases Phosphatases Excitotoxicity Ca 2+ Phospholipases Xanthine oxidase Nitric oxide synthase (NO) Heme oxygenase (CO) Endonucleases
21
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Glutamate accumulation Astrocyte Presynaptic Postsynaptic Astrocyte
22
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital NMDA Sodium and Calcium NMDA or glutamate Glycine Poly- amine H+H+ Phencyclidine Zinc Magnesium SH NO-S
23
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital AMPA, Kainate Sodium or Calcium AMPA Kainic acid or glutamate 2,3-benzo- diazepines
24
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Drug modification Decreased glutamate release –Adenosine derivatives, catecholamines –Sodium channel blockers l Phenytoin l Lamotrigine –Ca 2+ -channel blockers (L-type) l Nimodipine –Platelet activating factor antagonists
25
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Drug modification Glutamate receptor antagonism –Glutamate binding site –2,3-benzodiazepine site l GYKI 52466, ? very high dose diazepam –Glycine binding site l Felbamate –Receptor associated ion channel l Magnesium, ketamine, memantine –Redox modulatory site l Nitroglycerine, nitroprusside
26
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Opioids: Ventilation before Naloxone “Evidence supports efforts to correct respiratory acidosis and hypoxia followed by naloxone administration in patients suspected of opioid induced respiratory failure.” Class IIb
27
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Naloxone Dose IMI: 0.8mg –If systolic BP >100 mmHg IV: 0.4 mg –Cardiac arrest –If an IV line is in situ Repeated & titrated against response Rate of non-behavioural adverse reactions does not appear to be related to dose
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.